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Abstract This is a vital extension of our previously
published work. Thermo-responsive copolymer coated
superparamagnetic MnFe2O4 nanoparticles are tested for
cell viability and affinity on HeLa carcinoma cells under
different conditions. Nanoparticles were loaded with anti-
cancer drug doxorubicin. Composite nanoparticles of
average diameter 45 nm were of core–shell structure hav-
ing magnetic core of about 18 nm. Magnetic hyperthermia
effects on cell viability and drug delivery were studied by
exposing the cell suspension to high frequency magnetic
field, and living cells were quantified using MTT method.
There was almost absence of drug release at 37 C. Drug
was released at temperatures above lower critical solution
temperature (LCST) by magnetic heating. LCST of the
thermo-responsive copolymer was observed to be around
39 C. Below this temperature, copolymer was hydrophilic
and swelled. But above LCST, copolymer could become
hydrophobic, expel water and drug and shrink in volume.
Combination of hyperthermia and drug delivery effectively
treated cancer cells.
Keywords Biomaterials  Magnetic materials 
Nanostructures  Polymers
Introduction
There is a lot of research going on the biomedical
applications of magnetic nanoparticles (MNP) like mag-
netic resonance imaging, cell separation, localized
hyperthermia of cancer and controlled drug delivery.
Appropriate biocompatibility of materials is very impor-
tant, and in this regards iron oxide based magnetic
nanoparticles are of key significance. Magnetic field
gradient or any other efficient drug delivery system can
be used for delivering particles to the tumor sites. When
subjected to high frequency magnetic field, these nano-
particles generate heat due to Brownian, Ne´el and hys-
teresis losses (Shah et al. 2012). Around a temperature of
45 C, the healthy body cells remain safe but the cancer
cells become vulnerable to radiotherapy and chemother-
apy and might even perish completely (Shah 2012; Shah
et al. 2010a, b, 2011). This is the approximate tempera-
ture that results in mechanisms like protein denaturation,
DNA cross linking and apoptosis; all are different cancer
damaging mechanisms (Hildebrandt et al. 2002; Kumar
and Mohammad 2011; Santos-Marques et al. 2006; Suto
and Srivastava 1995). Tissue characteristics, magnetic
heater parameters and particles concentration are those
factors that influence the effectiveness of localized
hyperthermia (Kumar and Mohammad 2011; Raaphorst
et al. 1979; Shah et al. 2010a).
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The most demanding aspect of MNP is the tailoring of
multifunctional characteristics. Core–shell nanostructure is
of the utmost importance in which MNP serve as magnetic
cores. Opsonization and agglomeration are unwanted in
such applications and could be prevented by functionali-
zing the surfaces of nanoparticles with functional polymers
and/or surfactant layers that enhance the biocompatibility
and act as shells over cores (Gupta and Gupta 2005; Luong
et al. 2011; Martı´n-Saavedra et al. 2010). Anti-cancer drug
can be attached to these particles to deliver to the cancer
regions (Derfus et al. 2007; Kumar and Mohammad 2011).
Localized hyperthermia and controlled drug delivery are
two of the most pivotal purposes served simultaneously by
the core–shell nanoparticles.
Another important set of compounds that have attracted
huge attention in biomedical research are the functional
substances that respond to external stimuli such as pH and
temperature, etc. Thermo-responsive polymer PNIPAm
(poly-n-isopropylacrylamide) is one of such functional
compounds. It has an interesting characteristic of LCST
(lower critical solution temperature). Below LCST, it
absorbs water and swells in volume due to being hydro-
philic. Above the temperature it expels water due to being
hydrophobic and so shrinks in volume (Bromberg and Ron
1998; Hoffman 2002; Purushotham et al. 2009; SCHILD
1992; Schmaljohann 2006). By adjusting the temperature
of the polymer shell, drug release can be manipulated
resulting in higher release rates above LCST and vice versa
(Coughlan et al. 2004; Liu et al. 2005; Purushotham et al.
2009; Zhang and Misra 2007). Co-monomer units such as
acrylamide could be used to tune the LCST of PNIPAm
(Sershen et al. 2000).
Present work is an in vitro study of multifunctional
MnFe2O4 nanoparticles surface-modified with bilayer oleic
acid and coated with a thermo-responsive copolymer
PNIPAm-co-Am for controlled drug delivery and hyper-
thermia applications. Cell affinity and viability are studied
on HeLa carcinoma cells by MTT method. Figure 1 shows
the schematic overview of the processes involved in this
study.
Experimental
Current study is the vital extension of our previously
published work (Shah et al. 2012). Bilayer oleic acid-
modified MnFe2O4 magnetic nanoparticles (OA-MNP)
were prepared by co-precipitation method and coated with
PNIPAm-co-Am by emulsion polymerization. Anti-cancer
drug doxorubicin (DOX) was loaded into the copolymer
chains at 25 C. Detailed synthesis techniques of com-
posite nanoparticles (CNP) are described in our previous
work (Shah et al. 2012).
In vitro study
Magnetic hyperthermia and drug release
The in vitro study of composite magnetic nanoparticles was
carried out on HeLa carcinoma cells. Cell viability/cyto-
toxicity of nanoparticles was determined using MTT
method. MTT is a yellow, hydrophilic tetrazolium com-
pound. When this dye is added to the metabolically active
cells, it is converted into hydrophobic dark blue formazan
due to cleavage reduction of tetrazolium (Kim et al. 2009).
Formazan crystals are then dissolved in an organic com-
pound dimethylsulfoxide (DMSO) forming a colored
solution and then quantified by finding absorption at
570 nm. The resultant value corresponds to the number of
metabolically active cells. 30 mg CNP were added to HeLa
cells having concentration of 105 cells/ml and incubated
for 24 h at an atmosphere of 5 % CO2 and 37 C, to allow
the nanoparticles to bind to cells. After 24 h, suspension
was placed in a thermally insulating glass container and
placed within the heating coil of a magnetic heater oper-
ating at 7.2 kA/m magnetic field and 70 kHz frequency.
Magnetic heater was operated such that 45 C temperature
was maintained for 2, 4 and 6 h for three types of obser-
vations. After hyperthermia treatments, suspension was
placed in a 96-well plate and incubated for 12 h. Subse-
quently 20 ll of 5 mg/ml MTT was added to each well and
incubated for 4 h at 5 % CO2 and 37 C. Medium was
removed after 4 h and crystals of formazan were mixed in
200 ll of DMSO. The solution was vigorously mixed to
dissolve the reactants. Microplate reader (AMP Platos
R-496) was used at 570 nm to determine the absorbance of
each well. The relative cell viability percentage was
determined by comparing with the control-wells without
the magnetic nanoparticles.Fig. 1 Schematic overview of the processes involved in this study
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Cells affinity test
CNP (30 mg) were added to cell suspension of density
105 cells/ml and incubated for 24 h at 5 % CO2 and 37 C
to allow the nanoparticles to bind to cells. After 24 h,
magnetically bound cells were separated by magnetic
decantation. Supernatant was processed with MTT assay to
count the number of living cells after separating the mag-
netic cells. Cell affinity was determined by subtracting
from the total number of cells.
Results and discussions
There are two reasons why the surface modification of
MNP with OA was necessary as reported in last paper
(Shah et al. 2012). First, it was to synchronize the attach-
ment of the thermo-responsive copolymer to the MNP by
acting as an adhesive providing affinity. Second, was to be
used as a surfactant to curb the agglomeration existing
because of hydrophobic nature of MnFe2O4 and the dipole–
dipole interactions. Size of nanoparticles is of key signifi-
cance for biomedical applications. The most appropriate
size range of composite nanoparticles is about 10–50 nm
for drug delivery and hyperthermia applications
(Purushotham et al. 2009). The average diameter of CNP in
this work was about 45 nm, of which 18 nm was the
diameter of magnetic core. About 60 % (wt) of the
(hydrated) CNP was composed of water and organic
compounds and the remaining consisted of MnFe2O4 core.
Magnetic core was of pseudo single domain structure and
exhibited superparamagnetism due to lack of coercive
force (Shah et al. 2012). ‘Lower critical solution temper-
ature (LCST) of thermo-responsive copolymer was
observed to be 39 C. Below this temperature, copolymer
was hydrophilic and above this temperature, it became
hydrophobic and expelled water and drug.
In vitro study on HeLa carcinoma cells
Cells affinity
Composite nanoparticles were added to the cell culture
medium and incubated for 24 h to allow the nanoparticles
to attach with the cells. Figure 2 shows the cell capture
rates of MNP, OA-MNP and CNP determined by MTT
method. About 79 % of the cells captured nanoparticles
suggesting the appropriate cell affinities of CNP. MNP
showed only 20 % affinity to the cells in 24 h indicating
their passivity in attaching with the cells in uncoated form.
OA-modified nanoparticles showed capture rate of about
47 % cells. The rising of the cells affinity was due to the
biocompatible layers coated onto the particles. The
attachment with the cells probably occurred due to the
CH3
? functional groups of PNIPAm-co-Am copolymer
that might have interacted electrostatically with the nega-
tively charged glycocalyx on the surface of cancer cells.
Cancer cells are observed to be having a high density of
negative charge on their surfaces due to the sialic acid
residues and glycosaminoglycans on the cell membranes
(Kim et al. 2009).
In vitro magnetic hyperthermia
Magnetic hyperthermia characteristics of OA-MNP and
CNP were studied by incubating nanoparticles with cells in
culture medium for 24 h and then subjecting the suspen-
sion to alternating magnetic field of 7.2 kA/m and fre-
quency 70 kHz for 1 h. Temperature profile with time of
magnetic heating is shown in Fig. 3. For both observations
initial temperature was 25 C. For 60 min magnetic heat-
ing, CNP caused a temperature increase of about 47 C
while the temperature of the suspension containing OA-
MNP increased to about 67 C. It took 35 min for the
temperature of the CNP to rise up to 45 C, which is an
appropriate and effective temperature for hyperthermia
therapy. Various cellular damaging processes may occur at
this temperature like DNA cross linking, apoptosis and
protein denaturation (Hildebrandt et al. 2002; Kumar and
Mohammad 2011; Santos-Marques et al. 2006; Shah 2012;
Suto and Srivastava 1995). By adjusting more suitable
magnetic parameters like frequency and strength and the
concentration of magnetic particles, the magnetic heating
can be further optimized. As described earlier, size of the
magnetic core is about 18–20 nm that forms a pseudo
single domain structure. Particles exhibit superparamag-
netism due to the absence of remanence magnetization and
coercive force and heating occurs due to Brownian and
Ne´el losses. Swiftly changing direction of the magnetic
moments along the applied field within the crystal lattice
Fig. 2 Cell affinity of MNP, OA-MNP and CNP
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(internal dynamics) causes Ne´el relaxations. The torque of
magnetic moments under the alternating field is hindered
by the anisotropy energy (that attempts to align the
moments along a particular axis within the crystal lattice).
After the removal of applied field a reversible process of
the relaxation of moments takes place toward their equi-
librium position. Energy is dissipated in this process
resulting in Ne´el heating. Under an alternating field, there
also exists a physical rotation of the magnetic particles
within the fluid medium which causes Brownian heating
(external dynamics). Viscosity of the fluid is a determinant
for Brownian relaxations. Lesser the viscosity of the
medium, greater will be the Brownian heat loss and vice
versa.
Cell viability
Cell viability/cytotoxicity of composite nanoparticles was
studied using MTT assay on HeLa cells. Nanoparticles
were incubated with cells in culture medium for 24 h. Then
suspensions were placed at 33, 37 and 41 C for 6 h for
different observations and then incubated again for 12 h at
37 C. Figure 4 shows the cell viability because of DOX
release only in the absence of magnetic hyperthermia. Cell
viability was almost maximum for temperatures below
LCST where there was marginal DOX release due to dif-
fusion process and copolymer was hydrophilic holding
drug molecules in its chains. However, at 41 C tempera-
ture exceeded LCST, copolymer became hydrophobic and
expelled DOX that significantly reduced the cell viability
to about 63 % due to its anti-cancer effects. There was
almost absence of drug release at 37 C which is significant
because CNP holds drug molecules during their transpor-
tation through the blood capillaries, and drug will be
released to the surrounding only when temperature is made
to increase above LCST by magnetic hyperthermia.
Dehydrated composite nanoparticles (without DOX)
were incubated with cells for 24 h and then suspensions
were subjected to alternating magnetic field of 7.2 kA/m
and frequency 70 kHz in such a way that temperature
45 C was maintained for 2, 4 and 6 h for three different
observations. After magnetic heating each suspension was
incubated for 12 h. Figure 5 shows that keeping cells at
45 C for hours caused a remarkable decrease in the cell
viability and it dropped to about 18 % for 6 h magnetic
heating. Same experiment of magnetic heating for 2, 4 and
6 h was repeated with DOX-loaded composite particles.
Figure 6 shows that anti-cancer drug duly contributed to
kill the cancer cells due to its release at temperatures above
LCST and viability dropped to about 8 % for 6 h magnetic
heating.
Fig. 3 In vitro heat generation of OA-MNP and CNP under
alternating magnetic field
Fig. 4 Cell viability in the absence of magnetic heating (CNP
(hydrated) were incubated with cells in culture medium for 24 h.
Then suspensions were placed at 33, 37 and 41 C for 6 h for
different observations and then incubated again for 12 h at 37 C.)
Fig. 5 Cell viability in the presence of magnetic hyperthermia only
(dehydrated CNP (without DOX) were incubated with cells for 24 h
and then suspensions were subjected to alternating magnetic field of
7.2 kA/m and frequency 70 kHz in such a way that temperature 45 C
was maintained for 2, 4 and 6 h for three different observations)
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Moderate hyperthermia kills cancer cells by apoptosis or
at least weakens the cells to enhance the effectiveness of
additional procedures like radiotherapy and/or chemother-
apy. Therefore, hyperthermia is mostly applied in combi-
nations with other therapies and attaching anti-cancer drug
with magnetic nanoparticles in this study is for the purpose
of multifunctionality. Intensive hyperthermia may cause
cell death due to necrosis in which cytotoxic effect of high
temperature causes denaturation and coagulation of mem-
brane and cytoplasmatic proteins (Hildebrandt et al. 2002).
It is worth mentioning that in vivo conditions are more
favorable than in vitro for hyperthermia because in vivo
tumor cells are already under stress due to disorganized
vascular system, low oxygen, higher acidic concentration,
insufficient nutrients and unfavorable microenvironment.
So tumor cells are less able to tolerate the additional
stresses of hyperthermia than the healthy cells can do. It is
expected that if composite nanoparticles in this work are
examined in vivo, even better results may come out.
Conclusion
In vitro study was carried out on HeLa cells for cell affinity
and viability under different conditions. Hyperthermia
effects on cell viability were studied by exposing the cell
suspensions to high frequency magnetic field. There was
almost absence of drug release at 37 C. Drug was released
at temperatures above LCST due to magnetic hyperthermia
that damaged the cell viability due to the combination of
hyperthermia and drug effects. Composite particles
exhibited appropriate cell affinity.
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